In 2010 , the enterprise founded its sister company and second specialty , Drug Delivery International Ltd , to deliver its patented OralogiK™ technology and formulation development services . These two entities came together in 2017 , and merged into BDD Pharma
Ltd ( BDD ). The company has since developed an integrated clinical and manufacturing service that allows for the rapid evaluation of products in humans , saving its customers a great deal of time and money during product development .
128